SVV specifically identifies and kills cancer cells by recognizing Tumor endothelial marker 8 (TEM8), also known as Anthrax toxin receptor 1 (ANTXR1), a cell surface receptor highly expressed in cancer cells. This evidence concerns the gene CD177 and cancer.